ProfileGDS5678 / 1417426_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 111.145699
GSM967853U87-EV human glioblastoma xenograft - Control 211.722599
GSM967854U87-EV human glioblastoma xenograft - Control 311.299899
GSM967855U87-EV human glioblastoma xenograft - Control 411.308499
GSM967856U87-EV human glioblastoma xenograft - Control 512.261999
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 111.562199
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 211.487299
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 311.798699
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 411.286299
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 111.419999
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 211.268499
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 311.675899
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 410.975399
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 511.685699